Websites selling direct-to-consumer anti-Mullerian hormone tests often make statements about its potential use as a predictor of remaining fertility or time until menopause, that are not supported by evidence.
Results of a study published in JAMA Open Network of 27 websites selling hormone tests to women in the US, India, the UK, Australia, Canada, Ireland, and the Netherlands showed three quarters made misleading statements.
Related Articles
Blood test for male infertility developed using AI
An artificial intelligence (AI) model developed by scientists in Japan can predict male infertility using hormone levels in blood...
